Krop Julie Insider Trades

Insider Trading History

Track insider trading activity for Krop Julie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $0 0 shares
Last Trade
Jun 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$126k 25,000 shares
$5.03
$3.95
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $98.8k 25,000 shares
Last Trade
Jun 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$126k 25,000 shares
$5.03
$3.95
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $0 0 shares
Last Trade
Jun 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$126k 25,000 shares
$5.02
$3.95
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $199k 50,500 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$201k 50,500 shares
$3.99
$3.95
DiaMedica Therapeutics
DiaMedica Therapeutics DMAC
Chief Marketing Officer
Holding Value $3.44M 450,000 shares
Last Trade
Aug 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.06M 450,000 shares
$4.58
$7.64
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $166k 42,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$3.95
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $150k 38,000 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95k 38,000 shares
$2.50
$3.95
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $98.8k 25,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$50.5k 25,000 shares
$2.02
$3.95
Aquestive Therapeutics
Aquestive Therapeutics AQST
Director
Holding Value $98.8k 25,000 shares
Last Trade
Jun 22, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.7k 50,000 shares
$0.71
$3.95
Aquestive Therapeutics
Aquestive Therapeutics AQST
Holding Value $79k 20,000 shares
Last Trade
Jun 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.8k 20,000 shares
$4.04
$3.95
Aquestive Therapeutics
Aquestive Therapeutics AQST
Holding Value $113k 28,500 shares
Last Trade
Mar 11, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 28,500 shares
$5.30
$3.95
AMAG Pharmaceuticals
AMAG Pharmaceuticals AMAG
Chief Medical Officer
Holding Value $0 73,044 shares
Last Trade
Mar 02, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
AMAG Pharmaceuticals
AMAG Pharmaceuticals AMAG
Chief Medical Officer
Holding Value $0 81,877 shares
Last Trade
Feb 25, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
AMAG Pharmaceuticals
AMAG Pharmaceuticals AMAG
Chief Medical Officer
Holding Value $0 83,032 shares
Last Trade
Feb 23, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
AMAG Pharmaceuticals
AMAG Pharmaceuticals AMAG
Chief Medical Officer
Holding Value $0 81,399 shares
Last Trade
May 28, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
AMAG Pharmaceuticals
AMAG Pharmaceuticals AMAG
Chief Medical Officer
Holding Value $0 71,399 shares
Last Trade
Mar 02, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
AMAG Pharmaceuticals
AMAG Pharmaceuticals AMAG
Chief Medical Officer
Holding Value $0 72,646 shares
Last Trade
Mar 01, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
AMAG Pharmaceuticals
AMAG Pharmaceuticals AMAG
Chief Medical Officer
Holding Value $0 73,606 shares
Last Trade
Feb 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
AMAG Pharmaceuticals
AMAG Pharmaceuticals AMAG
Chief Medical Officer
Holding Value $0 48,606 shares
Last Trade
Feb 23, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00
AMAG Pharmaceuticals
AMAG Pharmaceuticals AMAG
Chief Medical Officer
Holding Value $0 49,475 shares
Last Trade
Jul 02, 2018 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up